HOLLY WILDS: Open Payments
NPI 1326487414 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 10 payments from 4 companies in 2025. Trend: 2023 $87 · 2024 $199 · 2025 $220
Food & beverage: $201Education: $19
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $171 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Calliditas Therapeutics US Inc. | 1 | $15 |
Products named: Vanrafia, Fabhalta, JARDIANCE, FARXIGA, TARPEYO.
Industry payments across MS — which companies pay providers there.
